🧠 Neurovascular Dysregulation and Microclot Persistence in COVID-19 Long-Haul Illnesses

November 24, 2025 | John Murphy | Leave a Comment

🧠 Neurovascular Dysregulation and Microclot Persistence in COVID-19 Long-Haul Illnesses

Author: John Murphy, President, COVID-19 Long-haul Foundation 📑 Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), affects millions globally and presents with persistent symptoms including fatigue, cognitive dysfunction,…[...]

September 19, 2025 | John Murphy | Leave a Comment

COVID-19 and immune dysregulation: Genomic pathways, clinical manifestations, and therapeutic strategies

John Murphy, CEO & President, COVID-19 Long-haul Foundation Abstract SARS-CoV-2 provokes a uniquely heterogeneous and dynamic immune response that ranges from efficient viral control to fulminant hyperinflammation and prolonged immune…[...]

September 4, 2025 | John Murphy | Leave a Comment

The Lingering Pandemic: Mapping the Arc of Long COVID and the Search for Recovery

By John Murphy, The COVID 19 Long-haul Foundation Introduction: A Pandemic That Didn’t End When the world first confronted SARS-CoV-2 in early 2020, the prevailing narrative was one of acute…[...]